On Monday 28 November, 2022, the European Council formally adopted the new Foreign Subsidies Regulation (FSR), aimed at tackling foreign...
The clock is ticking, but it’s not too late. As real estate investors are getting to grips with how the Register of Overseas Entities...
Under EU law, parallel importation is lawful subject to specific derogations that seek to protect human health and industrial and...
With geo-political and economic instability at an all-time high, corporate focus continues to be increasingly splintered. Have ESG goals,...
I recently had the privilege of visiting Zürich to meet colleagues and other lawyers working in the life sciences sector. During these...
If you have any questions on the regulation of cybersecurity in the UK, then the England & Wales chapter of the International Comparative...
On 22 November 2022, the UK Information Commissioner, John Edwards, emphasised the new approach to regulatory and enforcement action by...
As pressures grow on governments around the world to increase corporate transparency and disclosure, beneficial ownership registers have...
With the debt markets tightening in response to rising interest rates and economic volatility, Ropes & Gray partners Michael Lee, David...
It’s been a busy second half of the week in the EU regulatory landscape, with European authorities publishing further guidance on the...
In the last few months UK tax policy has been on a journey, a journey which has now ended up fairly close to where it started. Of course,...
As smartphone capabilities and the ubiquity of their usage increases, an increasing number of functions that were previously performed by...
On Monday, the European Supervisory Authorities (ESAs) announced a six month delay to its review of the principal adverse impact...
In a turbulent market, a sale and leaseback may be a win-win for both investor and tenant. The arrangement provides a liquidity solution...
Being an aspiring commercial lawyer often means being confronted by complex, often abstract, concepts leading to an often impenetrable...
Conference season continues with the Financial Times’s Global Pharma and Biotech Summit in London (November 2022). An impressive range of...